XERMELO (telotristat etiprate)
ANTIDIARRHEAL - TRYPTOPHAN HYDROXYLASE INHIBITOR · CARCINOID SYNDROME DIARRHEA
TERSERA THERAPE
Drug class
Antidiarrheal - Tryptophan Hydroxylase Inhibitor
Antidiarrheal tryptophan hydroxylase inhibitors are a targeted therapeutic class of medications designed to manage refractory diarrhea driven by excess peripheral serotonin production. Read more about Antidiarrheal - Tryptophan Hydroxylase Inhibitor
1 drugs in this class 1 manufacturers
Drugs in Antidiarrheal - Tryptophan Hydroxylase Inhibitor
Filter & compare in the drug finder →
Opens the drug finder with Antidiarrheal - Tryptophan Hydroxylase Inhibitor preselected. Add indication or manufacturer filters there.
Antidiarrheal tryptophan hydroxylase inhibitors are a targeted therapeutic class of medications designed to manage refractory diarrhea driven by excess peripheral serotonin production.
While the official FDA Established Pharmacologic Class is simply "tryptophan hydroxylase inhibitor," commercial compendia classify the agent under this combined functional heading.
Mechanistically, these agents inhibit tryptophan hydroxylase, the rate-limiting enzyme in serotonin biosynthesis, which suppresses peripheral serotonin production and normalizes serotonin-mediated gastrointestinal motility and intestinal fluid secretion.
Currently represented in clinical practice by telotristat ethyl, this class is primarily indicated for treating carcinoid syndrome diarrhea in adult patients with neuroendocrine tumors whose symptoms remain inadequately controlled by somatostatin analog therapy.
-
rxlist.com
Antidiarrheal tryptophan hydroxylase inhibitors are a targeted therapeutic class of medications designed to manage refractory diarrhea driven by excess peripheral serotonin production While the official FDA Established Pharmacologic Class is simply "tryptophan hydroxylase inhibitor," commercial compendia classify the agent under this combined functional heading Mechanistically, these agents inhibit tryptophan hydroxylase, the rate-limiting enzyme in serotonin biosynthesis, which suppresses perip...
-
globalrph.com
Antidiarrheal tryptophan hydroxylase inhibitors are a targeted therapeutic class of medications designed to manage refractory diarrhea driven by excess peripheral serotonin production
-
fda.gov
While the official FDA Established Pharmacologic Class is simply "tryptophan hydroxylase inhibitor," commercial compendia classify the agent under this combined functional heading
-
fda.gov
Mechanistically, these agents inhibit tryptophan hydroxylase, the rate-limiting enzyme in serotonin biosynthesis, which suppresses peripheral serotonin production and normalizes serotonin-mediated gastrointestinal motility and intestinal fluid secretion
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.